SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors designed for the topical treatment of retinal disease
8 December 2014 | By SciFluor Life Sciences
SciFluor Life Sciences, LLC announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,901,144 with claims covering the novel compound SF0166...